# Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment

> **NCT04751084** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Chinese University of Hong Kong** · enrollment: 675 (actual)

## Conditions studied

- IVF
- Intracytoplasmic Sperm Injection

## Interventions

- **DRUG:** Buscopan 20 milligrams/ML Injectable Solution

## Key facts

- **NCT ID:** NCT04751084
- **Lead sponsor:** Chinese University of Hong Kong
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-05-30
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-09-14
- **Target enrollment:** 675 (ACTUAL)
- **Last updated:** 2024-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04751084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04751084, "Buscopan in Patients Undergoing IVF/Intracytoplasmic Sperm Injection Treatment". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04751084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*